EVIDENCE LIBRARY
Small Intussusception Trial Did Not Demonstrate Shorter Reduction Time With Midazolam
A 32-child randomized trial reported more successful reductions numerically with midazolam, but neither that comparison nor procedure duration reached statistical significance.
A 32-child randomized trial reported more successful reductions numerically with midazolam, but neither that comparison nor procedure duration reached statistical significance.
The actual outcomes
Eisapour and colleagues randomized children with ileocolic intussusception to midazolam or placebo before attempted hydrostatic reduction. Fifteen of sixteen children in the midazolam group had successful reduction, compared with eleven of sixteen controls.
The reported success comparison had a p-value of 0.07. Mean successful-reduction duration was approximately 34.8 versus 32.7 minutes, with p=0.733. The trial therefore did not demonstrate the shorter duration suggested by its title.
A favorable-looking count is not conclusive proof
The numerical difference in success may justify further study, but the small sample leaves substantial uncertainty. Conversely, a nonsignificant result cannot prove that the intervention has no effect. The appropriate conclusion remains tied to the estimate and uncertainty.
The paper’s conclusion is more favorable than its statistical results alone support. The distinction between the authors’ interpretation and the measured comparisons should remain visible.
Implication for expert summaries
Report the denominators, success counts, and measured time rather than repeating the headline as an established effect. The study does not establish a general pediatric sedation protocol or show that midazolam is responsible for avoiding surgery in an individual child.
Source
Original analysis of the supplied paper: The Effect of Midazolam on Decreasing the Duration of Intussusception Hydrostatic Reduction in Child. Paper identifier: PMC4639339.